In this episode, we’re joined by Professor Kevin Harrington, one of the world’s leading experts in head and neck cancer, to break down what’s really changing in tongue cancer treatment, and what it means for patients today. We talk about the rise in younger patients without clear risk factors, why we still don’t fully understand why this is happening, and what that uncertainty means for the future. We also dive into immunotherapy: what it actually is, how it works, and why it’s starting to change outcomes in ways that simply weren’t possible before.
💬 Need Support?
If you’ve been diagnosed with tongue cancer (or are supporting someone who has), you can find help here:
Podden och tillhörande omslagsbild på den här sidan tillhör
Barbara Fountain. Innehållet i podden är skapat av Barbara Fountain och inte av,
eller tillsammans med, Poddtoppen.
